Zurück
K. Blennow
Aufstrebend42Sahlgrenska University Hospital
Kennzahlen
- h-Index
- —
- Zitationen
- —
- Publikationen
- —
Zusammensetzung
Evidenzstärke
50
Erst-/Letztautor
0
Seriosität
100
Erfahrungs-Indikator aus Bibliometrie und der Evidenzstärke der eigenen Studien — kein Qualitätsurteil über die Person.
Studien bei MedPulse
- 2026-05-01Das Gehirn-Immune-Protein sTREM2 mit langsamerem Gedächtnisverlust bei älteren Menschen verbunden
- 2026-04-01Alterations in CSF Amyloid-β and Tau Biomarkers in Former College and Professional American Football Players: Findings from the DIAGNOSE CTE Research Project.
- 2026-03-01Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia.
- 2026-02-01Cerebrospinal fluid levels of neurogranin and YKL-40 in mild cognitive impairment due to Alzheimer's disease or vascular dementia.
- 2026-01-29Glymphatic dysfunction links vascular pathology to Alzheimer's biomarkers and cognitive decline.
- 2026-01-14Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use.
- 2026-01-13Plasma platelet-derived growth factor receptor-β decrease correlates with blood-brain barrier damage in Alzheimer's disease.
- 2026-01-01Elecsys pTau217 plasma immunoassay detection of amyloid pathology in clinical cohorts.
- 2026-01-01Increased cerebrospinal fluid YKL-40 concentration in hip fracture patients with delirium.